The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis Patients
Abstract
Tissue advanced glycation end products (AGE) are a measure of cumulative metabolic stress and trigger cytokines driven inflammatory reactions. AGE are thought to contribute to the chronic complications of diabetes and ESRD. Tissue autofluorescence is related to the accumulation of AGE. Therefore, skin autofluorescence (AF) may provide prognostic information on mortality in hemodialysis (HD) patients. Skin AF was measured noninvasively with an AF reader at baseline in 109 HD patients. Overall and cardiovascular mortality was monitored prospectively during a period of 3 yr. The AF reader was validated against AGE contents in skin biopsies from 29 dialysis patients. Forty-two of the 109 (38.5%) HD patients died. Cox regression analysis showed that AF was an independent predictor of overall and cardiovascular mortality (for overall mortality odds ratio [OR] 3.9), as were pre-existing cardiovascular disease (CVD; OR 3.1), C-reactive protein (OR 1.1), and serum albumin (OR 0.3). Multivariate analysis revealed that 65% of the variance in AF could be attributed to the independent effects of age, dialysis and renal failure duration, presence of diabetes, triglycerides levels, and C-reactive protein. AF was also independently linked to the presence of CVD at baseline (OR 8.8; P < 0.001). AF correlated with collagen-linked fluorescence (r = 0.71, P < 0.001), pentosidine (r = 0.75, P < 0.001), and carboxy(m)ethyllysine (both r = 0.45, P < 0.01). Skin AF is a strong and independent predictor of mortality in ESRD. This supports a role for AGE as a contributor to mortality and CVD and warrants interventions specifically aimed at AGE accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Self-citationLowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,976
Epidemiology of cardiovascular disease in chronic renal disease.
Foley, R. N., Parfrey, P. S., & Sarnak, M. J. (1998) · PubMed · Cited by 1,252
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R., & Baynes, J. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116481 · Cited by 769
Self-citationSimple non-invasive assessment of advanced glycation endproduct accumulation
Meerwaldt, R., Graaff, R., Oomen, P. H. N., Links, T. P., Jager, J. J., Alderson, N. L., Thorpe, S. R., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1451-2 · Cited by 766
Self-citationOxidative stress in end-stage renal disease: an emerging threat to patient outcome
Locatelli, F., Canaud, B., Eckardt, K.-U., Stenvinkel, P., Wanner, C., & Zoccali, C. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg074 · Cited by 758
Aronson, D. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00002 · Cited by 651
Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence
Monnier, V. M., Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P., & Kohn, R. R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602133140702 · Cited by 585
Diabetes Control and Complications Trial
Yue, D., Colagiuri, S., McElduff, A., & Silink, M. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141357.x · Cited by 575
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
Glycoxidation and lipoxidation in atherogenesis
Baynes, J. W., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 514
Self-citationYan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
Bucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 474
Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel, B. H. R., Boulanger, C. M., Crijns, F. R. L., Huijberts, M. S. P., Poitevin, P., Swennen, G. N. M., Vasan, S., Egan, J. J., Ulrich, P., Cerami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4630 · Cited by 434
Miyata, T., Wada, Y., Cai, Z., Iida, Y., Horie, K., Yasuda, Y., Maeda, K., Kurokawa, K., & De Strihou, C. V. Y. (1997) · Kidney International · doi:10.1038/ki.1997.160 · Cited by 352
THORPE SR ROLE OF OXIDATIVE STRESS IN DIABETIC COMPLICATIONS: A NEW PERSPECTIVE ON AN OLD PARADIGM
Baynes, J. (1999) · Cited by 326
Self-citationvan Dijk, P. C. W., Jager, K. J., de Charro, F., Collart, F., Cornet, R., Dekker, F. W., Grönhagen‐Riska, C., Kramar, R., Leivestad, T., Simpson, K., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.6.1120 · Cited by 307
Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries
Zhang, L., Zalewski, A., Liu, Y., Mazurek, T., Cowan, S., Martin, J. L., Hofmann, S. M., Vlassara, H., & Shi, Y. (2003) · Circulation · doi:10.1161/01.cir.0000080378.96063.23 · Cited by 279
Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
Forbes, J. M., Thallas, V., Thomas, M. C., Founds, H. W., Burns, W. C., Jerums, G., & Cooper, M. E. (2003) · The FASEB Journal · doi:10.1096/fj.02-1102fje · Cited by 263
Advanced glycation end products and mortality in hemodialysis patients
Schwedler, S. B., Metzger, T., Schinzel, R., & Wanner, C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00423.x · Cited by 195
He, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Meerwaldt, R., Links, T. P., Graaff, R., Hoogenberg, K., Lefrandt, J. D., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1828-x · Cited by 181
Self-citationWendt, T., Bucciarelli, L., Qu, W., Lu, Y., Yan, S. F., Stern, D. M., & Schmidt, A. M. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0024-4 · Cited by 176
Nicholl, I. D., Stitt, A. W., Moore, J. E., Ritchie, A. J., ARCHER, D. B., & Bucala, R. (1998) · Molecular Medicine · doi:10.1007/bf03401759 · Cited by 152
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients
Wanner, C., & Metzger, T. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_8.29 · Cited by 148
Huijberts, M. S., Wolffenbuttel, B. H. R., Struijker-Boudier, H. A. J., Crijns, F. R. L., Kruseman, A. C. N., Poitevin, P., & Levy, B. I. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116716 · Cited by 140
Busch, M., Franke, S., Müller, A., Wolf, M., Gerth, J., Ott, U., Niwa, T., & Stein, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00736.x · Cited by 136
Relevance of oxidative and carbonyl stress to long-term uremic complications
Miyata, T., Kurokawa, K., & de Strihou, C. V. Y. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07615.x · Cited by 119
Advanced Glycation End Products in Nondiabetic Patients With Coronary Artery Disease
Kanauchi, M., Tsujimoto, N., & Hashimoto, T. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1620 · Cited by 111
Baynes, J. (2000) · Biogerontology · doi:10.1023/a:1010034213093 · Cited by 99
Self-citationGaller, A., Müller, G., Schinzel, R., Kratzsch, J., Kieß, W., & Münch, G. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2609 · Cited by 82
Davis, B. J., Forbes, J. M., Thomas, M. C., Jerums, G., Burns, W. C., Kawachi, H., Allen, T. J., & Cooper, M. E. (2004) · Diabetologia · doi:10.1007/s00125-003-1256-8 · Cited by 66
Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease
Mathur, S., Devaraj, S., & Jialal, I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200203000-00003 · Cited by 64
Hricik, D. E., Wu, Y. C., Schulak, J. A., & Friedlander, M. A. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00747.x · Cited by 59
Daoud, S., Schinzel, R., Neumann, A., Loske, C., Fraccarollo, D., Diez, C., & Simm, A. (2001) · Molecular Medicine · doi:10.1007/bf03401860 · Cited by 57
Cited by
Advanced glycation end products in the pathogenesis of chronic kidney disease
Rabbani, N., & Thornalley, P. J. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.034 · Cited by 387
Advanced Glycation End-Products (AGEs) and Heart Failure: Pathophysiology and Clinical Implications
Hartog, J. W. L., Voors, A. A., Bakker, S. J. L., Smit, A. J., & van Veldhuisen, D. J. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.09.009 · Cited by 299
Self-citationSkin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes
Meerwaldt, R., Lutgers, H. L., Links, T. P., Graaff, R., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2007) · Diabetes Care · doi:10.2337/dc06-1391 · Cited by 287
Self-citationSkin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes
Lutgers, H. L., Graaff, R., Links, T. P., Ubink-Veltmaat, L. J., Bilo, H. J., Gans, R. O., & Smit, A. J. (2006) · Diabetes Care · doi:10.2337/dc05-2173 · Cited by 264
Self-citationNutrition and aging skin: Sugar and glycation
Danby, F. W. (2010) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2010.03.018 · Cited by 107
Metadata
- Authors
- Meerwaldt, R., Hartog, J. W. L., Graaff, R., Huisman, R. J., Links, T. P., den Hollander, N. C., Thorpe, S. R., Baynes, J. W., Navis, G., Gans, R. O. B., & Smit, A. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-12
- Volume
- 16
- Issue
- 12
- Pages
- 3687-3693
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2163425767
- Cited by
- 396
- References
- 41
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.